Nicholas Heming

ORCID: 0000-0002-4537-7595
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Intensive Care Unit Cognitive Disorders
  • Respiratory Support and Mechanisms
  • Sepsis Diagnosis and Treatment
  • Adrenal Hormones and Disorders
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Renal function and acid-base balance
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Cardiac Arrest and Resuscitation
  • Tracheal and airway disorders
  • SARS-CoV-2 and COVID-19 Research
  • Pneumonia and Respiratory Infections
  • Anesthesia and Sedative Agents
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • EEG and Brain-Computer Interfaces
  • Hemodynamic Monitoring and Therapy
  • Epilepsy research and treatment
  • Heme Oxygenase-1 and Carbon Monoxide
  • Voice and Speech Disorders
  • Peripheral Neuropathies and Disorders
  • Immune Response and Inflammation
  • Thermal Regulation in Medicine
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pharmacological Effects and Toxicity Studies
  • Nosocomial Infections in ICU

Hôpital Raymond-Poincaré
2015-2024

Assistance Publique – Hôpitaux de Paris
2015-2024

Université Paris-Saclay
2018-2024

Université de Versailles Saint-Quentin-en-Yvelines
2018-2024

Inserm
2015-2024

Infection et inflammation
2017-2024

Hôpital Antoine-Béclère
2023

Institut thématique Immunologie, inflammation, infectiologie et microbiologie
2020-2022

Weatherford College
2020

Délégation Paris 7
2010-2019

Early diagnosis of coronavirus disease 2019 (COVID-19) is the utmost importance but remains challenging. The objective current study was to characterize exhaled breath from mechanically ventilated adults with COVID-19. In this prospective observational study, we used real-time, online, proton transfer reaction time-of-flight mass spectrometry perform a metabolomic analysis expired air undergoing invasive mechanical ventilation in intensive care unit due severe COVID-19 or non-COVID-19 acute...

10.1016/j.ebiom.2020.103154 article EN cc-by-nc-nd EBioMedicine 2020-12-04

<h2>Abstract</h2><h3>Background</h3> Complement pathway inhibition may provide benefit for severe acute respiratory illnesses caused by viral infections such as COVID-19. We present results from a nonrandomized proof-of-concept study of complement C5 inhibitor eculizumab treatment <h3>Methods</h3> All patients (<i>N</i> = 80) with confirmed SARS-CoV-2 infection and COVID-19 admitted to our intensive care unit between March 10 May 5, 2020 were included. Forty-five treated standard 35 plus...

10.1016/j.eclinm.2020.100590 article EN cc-by-nc-nd EClinicalMedicine 2020-11-01

Abstract Background Severe acute respiratory syndrome coronavirus-2 (SARS–CoV-2)-induced distress (ARDS) causes high mortality. Umbilical cord-derived mesenchymal stromal cells (UC-MSCs) have potentially relevant immune-modulatory properties, whose place in ARDS treatment is not established. This phase 2b trial was undertaken to assess the efficacy of UC-MSCs patients with SARS–CoV-2-induced ARDS. Methods multicentre, double-blind, randomized, placebo-controlled (STROMA–CoV-2) recruited...

10.1186/s13054-022-03930-4 article EN cc-by Critical Care 2022-02-21

Sepsis is associated with increased mortality, delirium and long-term cognitive impairment in intensive care unit (ICU) patients. Electroencephalogram (EEG) abnormalities occurring at the acute stage of sepsis may correlate severity brain dysfunction. Predictive value early standard EEG for mortality ICU septic patients remains to be assessed.In this prospective, single center, observational study, was performed, analyzed classified according both Synek Young scales, consecutive acutely...

10.1371/journal.pone.0139969 article EN cc-by PLoS ONE 2015-10-08

Abstract Infection with SARS-CoV-2 variant Omicron is considered to be less severe than infection Delta, rarer occurrence of disease requiring intensive care. Little information available on comorbid factors, clinical conditions and specific viral mutational patterns associated the severity infection. In this multicenter prospective cohort study, patients consecutively admitted for COVID-19 in 20 care units France between December 7th 2021 May 1st 2022 were included. Among 259 patients, we...

10.1038/s41467-022-33801-z article EN cc-by Nature Communications 2022-10-12
Nicholas Heming Alain Renault Emmanuelle Kuperminc Christian Brun‐Buisson Bruno Mégarbane and 95 more Jean‐Pierre Quenot Shidasp Siami Alain Cariou Xavier Forceville Carole Schwebel Marc Léone Jean‐François Timsit Benoît Misset Mohamed Ali Benali Gwenhaël Colin Bertrand Souweine Karim Asehnoune Emmanuelle Mercier Loïc Chimot Claire Charpentier Bruno François Thierry Boulain Frank Petitpas Jean Michel Constantin Gilles Dhonneur François Baudin Alain Combes Julien Bohé Jean-François Loriferne Fabrice Cook Michel Slama O. Leroy Gilles Capellier Auguste Dargent Tarik Hissem Rania Bounab Virginie Maxime Pierre Moine Éric Bellissant Djillali Annane Djillali Annane B. Christian MISSET Benoit CHASTRE Jean BRIVET François B. Julien SCHWEBEL Carole SIAMI Shidasp SLAMA Michel LEROY Olivier CAPELLIER Gilles W Michel ALI BEN ALI Mohamed ANTONINI François LORIFERNE Jean-François PETITPAS Franck CHARPENTIER Claire Constantin Jean-Michel D'HONNEUR Gilles S. Bertrand F. Xavier Mégarbane Bruno BAUDIN Francois COLIN Gwenhaël Karim Asehnoune QUENOT Jean-Pierre François Bruno B. Thierry MERCIER Emmanuelle Jean Reignier A Carvalho Roland COOK Fabrice CARIOU Alain CHIMOT Loic F Fouad Polito Andrea Clair Bernard Virginie Maxime L David Tarek Sharshar David Orlikowski RAZAZI Keyvan DE PROST Nicolas CARTEAUX Guillaume GARROUSTE ORGEAS Maité Philippart François Alain Combes Nieszkowska Ania Jacobs Frédéric Prat Dominique Lafforgue Patrick ARA SOMOHANO Claire MINET Clémence LUGOSI Maxime Maizel Julien Navellou Jean Christophe Mourvillier Bruno Lila Bouadma Timsit Jean François Martin Claude Denis

10.1016/s2213-2600(23)00430-7 article EN publisher-specific-oa The Lancet Respiratory Medicine 2024-02-02
Vincent Labbé Damien Contou Nicholas Heming Bruno Mégarbane Keyvan Razazi and 95 more Florence Boissier Hafid Ait‐Oufella Matthieu Turpin Serge Carreira Alexandre Robert Mehran Monchi Bertrand Souweine Sébastien Préau Denis Doyen Emmanuel Vivier Noémie Zucman Martin Dres Mohamed Fejjal Élise Noël-Savina Marwa Bachir Karim Jaffal Jean‐François Timsit Santiago Alberto Picos Éric Mariotte Nihal Martis William Juguet Giovanna Melica Paul Rondeau Étienne Audureau Armand Mekontso Dessap Gaetan Plantefevre Djillali Annane Aurélien Dinh Lilia Abdeladim Rania Bounab Pierre Moine Virginie Maxime Hayette Tessa Miguel Carlos Emmanuelle Kuperminc Sébastian Voicu Isabelle Malissin Nicolas Deye Aymen Mrad Thomas Lacoste-Palasset Thomas Lefèvre Luc Haudebourg Jean-Michel Ekhérian François Bagate Nicolas de Prost Guillaume Carteaux Inès Bendib Samuel Tuffet Julien Lopinto Pascale Labedade Gaêl Michaud Brice Benelli Anne Fleur Haudebourg Ségolène Gendreau Emilio Berti Astrid Bertier Romain Arrestier Paul Masi E. Dufranc Rémi Coudroy Arnaud W. Thille Anne Veinstein Delphine Chatellier Jean‐Pierre Frat Maeva Rodriguez Faustine Reynaud Victor De Roubin François Arrivé Paul Gabarre Diane Bollens Patrick Ingiliz Bénédicte Lefebvre Zineb Ouazene Thibault Chiarabini Nadia Valin Tomas Urbina Vincent Bonny Naïke Bigé Karine Lacombe Muriel Fartoukh Cyrielle Desnos Guillaume Voiriot Michel Djibré Clarisse Blayau Aude Gibelin Julien Dessajan Ludovic Lassel Pierre-Marie Bertrand Raphael Chambon Nicolas Clément Oumar Sy Sébastien Jochmans Claire Dupuis Laure Calvet François Thouy

Given the high risk of thrombosis and anticoagulation-related bleeding in patients with hypoxemic COVID-19 pneumonia, identifying lowest effective dose anticoagulation therapy for these is imperative.To determine whether therapeutic (TA) or high-dose prophylactic (HD-PA) decreases mortality and/or disease duration compared standard-dose (SD-PA), TA outperforms HD-PA; to compare net clinical outcomes among 3 strategies.The ANTICOVID randomized open-label trial included pneumonia requiring...

10.1001/jamainternmed.2023.0456 article EN JAMA Internal Medicine 2023-03-22

Acetazolamide has been used for decades as a respiratory stimulant patients with chronic obstructive pulmonary disease (COPD) and metabolic alkalosis, but no large randomized placebo-controlled trial is available to confirm this approach.To determine whether acetazolamide reduces mechanical ventilation duration in critically ill COPD alkalosis.The DIABOLO study, randomized, double-blind, multicenter trial, was conducted from October 2011 through July 2014 15 intensive care units (ICUs)...

10.1001/jama.2016.0019 article EN JAMA 2016-02-02

10.1097/00007611-195109000-00003 article EN Southern Medical Journal 1951-09-01

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes disease 2019 (COVID-19) through excessive end organ inflammation. Despite improved understanding of the pathophysiology, management, and great efforts worldwide to produce effective drugs, death rates COVID-19 patients remain unacceptably high, treatment is unfortunately lacking. Pharmacological strategies aimed at modulating inflammation in are being evaluated worldwide. Several drug therapies targeting this...

10.3389/fmed.2021.625836 article EN cc-by Frontiers in Medicine 2021-05-07

We describe a retrospective review of 38 cases reconstruction following resection the metaphysiodiaphysis lower limb for malignant bone tumours using free vascularised fibular grafts. The mean follow-up was 7.6 years (0.4 to 18.4). Musculoskeletal Tumor Society score 27.2 (20 30). significantly higher when graft carried out in one-stage procedure after tumour rather than two stages. Bony union achieved 89% cases. overall time 1.7 (0.2 10.3). Free transfer is major operation with frequent,...

10.1302/0301-620x.92b11.23832 article EN Journal of Bone and Joint Surgery - British Volume 2010-11-01
Coming Soon ...